| |
NZ European
|
Māori
|
All cancers
| | | |
|---|
|
Characteristic
|
(N = 1459)
|
Earlya
|
(N = 311)
|
Earlya
|
(N = 1846)
|
Earlya
| | | |
|---|
| |
n (%)
|
n (%)
|
n (%)
|
n (%)
|
n (%)
|
n (%)
|
OR
|
95% CI
|
p
|
|---|
|
Screening status
| | | | | | | | |
<0.001
|
| |
Screen detected
|
915 (62.7)
|
654 (71.5)
|
153 (49.2)
|
107 (69.9)
|
1106 (59.9)
|
786 (71.1)
|
Ref
| | |
| |
Interval
|
192 (13.2)
|
63 (32.8)
|
20 (6.4)
|
3 (15.0)
|
218 (11.3)
|
69 (31.7)
|
5.30
|
4.15-6.74
| |
| |
Non-screen
|
352 (24.1)
|
118 (33.5)
|
138 (44.4)
|
36 (26.1)
|
522 (28.3)
|
162 (31.0)
|
5.46
|
4.11-7.33
| |
|
Age group (years)
| | | | | | | | | |
| |
45-49
|
208 (14.3)
|
110 (52.9)
|
51 (16.4)
|
23 (45.1)
|
275 (14.9) b
|
143 (52.0)
|
Ref
| |
0.005
|
| |
50-54
|
375 (25.7)
|
206 (54.9)
|
77 (24.8)
|
31 (40.3)
|
469 (25.4)
|
245 (52.2)
|
0.99
|
0.74-1.33
| |
| |
55-59
|
323 (22.1)
|
180 (55.7)
|
74 (23.8)
|
32 (43.2)
|
416 (22.5)
|
218 (52.4)
|
0.98
|
0.73-1.33
| |
| |
60-64
|
337 (23.1)
|
196 (58.2)
|
73 (23.5)
|
36 (49.3)
|
425 (23.0)
|
241 (56.7)
|
0.83
|
0.61-1.12
| |
| |
65-69
|
216 (14.8)
|
143 (66.2)
|
36 (11.6)
|
24 (66.7)
|
261 (14.1) b
|
170 (65.1)
|
0.58
|
0.41-0.82
| |
|
Deprivation
| | | | | | | | | |
| |
Dep 1-2
|
184 (12.6)
|
101 (54.9)
|
9 (2.9)
|
1 (11.1)
|
203 (11.0)
|
108 (53.2)
|
Ref
| |
0.094
|
| |
Dep 3-4
|
157 (10.8)
|
104 (66.2)
|
23 (7.4)
|
13 (56.5)
|
186 (10.1)
|
120 (64.5)
|
0.63
|
0.42–0.94
| |
| |
Dep 5-6
|
339 (23.2)
|
189 (55.8)
|
62 (19.9)
|
29 (46.8)
|
411 (22.3)
|
223 (54.3)
|
0.96
|
0.68–1.34
| |
| |
Dep 7-8
|
492 (33.7)
|
279 (56.7)
|
95 (30.5)
|
43 (45.3)
|
614 (33.3)
|
338 (55.0)
|
0.93
|
0.68–1.28
| |
| |
Dep 9-10
|
287 (19.7)
|
162 (56.4)
|
122 (39.2)
|
60 (49.2)
|
432 (23.4)
|
228 (52.8)
|
1.02
|
0.73–1.42
| |
|
Residence
| | | | | | | | | |
| |
Urban
|
783 (53.7)
|
435 (55.6)
|
150 (48.2)
|
75 (50.0)
|
990 (53.6)
|
539 (54.4)
|
Ref
| |
0.794
|
| |
Semi-urban
|
370 (25.4)
|
222 (60.0)
|
107 (34.4)
|
50 (46.7)
|
492 (26.7)
|
277 (56.3)
|
0.93
|
0.75–1.15
| |
| |
Rural
|
306 (21.0)
|
178 (58.2)
|
54 (17.4)
|
21 (38.9)
|
364 (19.7)
|
201 (55.2)
|
0.97
|
0.76–1.23
| |
|
Year of diagnosis
| | | | | | | | | |
| |
1999-2002
|
249 (17.1)
|
128 (51.4)
|
44 (14.1)
|
20 (45.5)
|
300 (16.3)
|
153 (51.0)
|
Ref
| |
0.423
|
| |
2003-2006
|
450 (30.8)
|
270 (60.0)
|
75 (24.1)
|
33 (44.0)
|
542 (29.4)
|
308 (56.8)
|
0.79
|
0.60-1.05
| |
| |
2007-2009
|
363 (24.9)
|
203 (55.9)
|
86 (27.7)
|
45 (52.3)
|
479 (25.9)
|
263 (54.9)
|
0.86
|
0.64-1.14
| |
| |
2010-2012
|
397 (27.2)
|
234 (58.9)
|
106 (34.1)
|
48 (45.3)
|
525 (28.4)
|
293 (55.8)
|
0.82
|
0.62-1.09
| |
- (Characteristics of women associated with early stage [compared with advanced stage] at diagnosis of breast cancer by ethnicity for screening age women with newly diagnosed breast cancer in the Waikato, New Zealand 1999–2012).
- (aearly stage = in-situ & stage I, bonly cancers diagnosed from July 2004 onwards are included).
